Quantitative Proteomics for Translational Pharmacology and Precision Medicine: State of The Art and Future Outlook

Abstract

Over the past 20 years, quantitative proteomics has contributed a wealth of protein expression data, which are currently used for a variety of systems pharmacology applications, as a complement or a surrogate for activity of the corresponding proteins. A symposium at the 25th North American ISSX meeting, in Boston, in September 2023, was held to explore current and emerging applications of quantitative proteomics in translational pharmacology and strategies for improved integration into model-informed drug development based on practical experience of each of the presenters. A summary of the talks and discussions is presented in this perspective alongside future outlooks that were outlined for future meetings. Significance StatementThis perspective explores current and emerging applications of quantitative proteomics in translational pharmacology and precision medicine and outlines outlooks for improved integration into model-informed drug development.